30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

A First Look at 2010 Results: Wright Medical

$518.9MM, +6% (U.S. %, ex-U.S. %)
* Hips $176.6MM, +5% (U.S. -3%, ex-U.S. +11%)
* Knees $128.8MM, +5% (U.S. +2%, ex-U.S. +10%)
* Biologics $79.2MM, +0.1% (U.S. flat, ex-U.S. +1%)
* Extremities $124.4MM, +16% (U.S. +14%, ex-U.S. +26%)
* Other $9.7MM, -11%

* U.S. hip/knee experienced modest price declines, average selling prices flat for 4Q
* U.S. sales buoyed by accelerating extremities growth rate, favorable early results from launch of EVOLUTION Medial-Pivot knee
* Noting stabilization in procedure volumes
* 4th consecutive year of extremities growth in excess of 15%
* Extremities + biologics = ~40% of global business, >50% of U.S. business
* >175 focused foot/ankle sales reps in U.S.; will continue expansion in 2011
* 2011 launches include EVOLVE Elbow Plating system, DARCO Reconstructive Plate in Japan, FUSIONFLEX Bone Matrix, PRO-TOE Hammertoe System (currently in limited release, full launch due in 1Q11)
* Expecting 2H11 revenue growth to be slightly better than 1H11